维普中文期刊产品整合服务
9篇 您的检索式:作者名="Abdullah Erdem"
    题名 作者 年代 出处 被引量
1Robotic radical prostatectomy in high-risk prostate -ancer: current perspectives显示文摘Abdullah Erdem Canda Mevlana Derya Balbay 2015Asian Journal of Andrology2015,17,6:5
2Comparison of two different treatment regimens’ efficacy in neovascular age-related macular degeneration in Turkish population—based on real life data-Bosphorus RWE Study Group显示文摘AIM: To compare two different anti-vascular endothelial growth factor(anti-VEGF) treatment regimens'-a priori pro re nata(PRN) and PRN regimen following^(th)e loading phaseanatomical and functional results in neovascular agerelated macular degeneration(n AMD) patients. METHODS: Totally 544 n AMD patients followed and treated with aflibercept(n=135) and ranibizumab(n=409)at 9 different centers between 2013 and 2015 were enrolled into^(th)is retrospective multicenter study. Patients with initial best corrected visual acuity(BCVA) interval of 1.3-0.3(log MAR) and a minimum follow-up of 12 mo were included. Patients under two different regimens-a priori pro re nata(1+PRN) or 3 consecutive intravitreal injections followed by a PRN regimen(3+PRN)-were compared in BCVA at 3^(th), 6^(th) and 12^(th) months, and in central macular^(th)ickness(CMT) at 6^(th) and 12^(th) months. The total study group, intravitreal ranibizumab(IVR) and intravitreal aflibercept(IVA) groups were evaluated separately. RESULTS: The mean CMT decreased in^(th)e 1+PRN(n=101) regimen from 407 to 358 and 340 μm and in^(th)e 3+PRN(n=443) group from 398 to 318 and finally to 310 μm at months 6 and 12, respectively. Anatomically,^(th)e CMT reduction at 6^(th) month(48.5 vs 76.4;P<0.05) was statistically significant in favor of 3+PRN group. BCVA changed in 1+PRN group from 0.77 to 0.78, 0.75 and 0.75;in 3+PRN group from 0.81 to 0.69, 0.72, and 0.76 at months 3, 6, and 12, respectively. Visual gain was statistically better in 3+PRN group at 3^(th) month(-0.01 vs 0.12;P<0.001). In IVR group, CMT reduction was in greater in 3+PRN at 6^(th)(44 vs 72) and 12^(th) month(61 vs 84), but statistically insignificant. The 3+PRN group revealed statistically better visual results at 3^(th) month(-0.02 vs 0.11, P<0.05). In IVA group, although statistically insignificant, CMT reduction(61 vs 89, 6^(th) month;85 vs 97, 12^(th) month) and visual gain(0.02 vs 0.16;0.02 vs 0.14;0.05 vs 0.11) was found in favor of 3+PRN group at all visits.CONCLUSION: The loading dose of anti-VEGF treatments in n AMD leads to significantly better anatomical and functional results, regardless of the agent, specially in early follow-up interval.Burak Erden Selim Bolükbasi Abdullah Ozkaya Levent Karabas Cengiz Alagoz Zeynep Alkin Ozgür Artunay Sadik Etka Bayramoglu Gokhan Demir Mehmet Demir Ali Demircan Gürkan Erdogan Mehmet Erdogan Erdem Eris Havva Kaldirim Ismail Umut Onur Ozen Ayranci Osmanbasoglu Sezin Ozdogan Erkul Mine Oztürk Irfan Perente Kübra Sarici Nihat Sayin Dilek Yasa Ihsan Yilmaz Zeynep Yilmazabdurrahmanoglu 2020International Journal of Ophthalmology(English edition)2020,13,1:1
3Transthoracic echocardiographic guidance during transcatheter closure of atrial septal defects in children and adults显示文摘Abdullah Erdem Turkay Sar?tas Cenap Zeybek Ilker Kemal Yucel Nurdan Erol Halil Dem?r Ender Odem?s Yalim Yalc?n Ahmet Celeb? 2013The International Journal of Cardiovascular Imaging2013,,1:1
4Transthoracic echocardiographic guidance during transcatheter closure of atrial septal defects in children and adults显示文摘Abdullah Erdem Turkay Sar?tas Cenap Zeybek Ilker Kemal Yucel Nurdan Erol Halil Dem?r Ender Odem?s Yalim Yalc?n Ahmet Celeb? 2013The International Journal of Cardiovascular Imaging2013,,1:1
5Transthoracic echocardiographic guidance during transcatheter closure of atrial septal defectsin children and adults 显示文摘Abdullah Erdem Turkay Sar tas Cenap Zeybek 2013Int J Cardinvasc Imaging2013,29,1:1
6Comment on amniotic membrane covering promotes healing of cornea epithelium and improves visual acuity after debridement for fungal keratitis显示文摘Dear Editor,We congratulate Zeng et al[1]for their study entitled'Amniotic membrane covering promotes healing of cornea epithelium and improves visual acuity after debridement for fungal keratitis'.The authors endeavored to present an alternative method for ophthalmologists in the treatment of a challenging case.We would like to express our reservations and ask for the attitudes of the authorsAhmet Tas Abdullah Ilhan Umit Yolcu Uzeyir Erdem 2015International Journal of Ophthalmology(English edition)2015,8,3:0
7The 14^th International Prostate Forum显示文摘The International Prostate Forum(IPF)originally started with three urology departments in Japan,Turkey,and the United States.The forum focused on talks and presentations with discussions covering almost all areas of prostatic diseases,including both benign prostatic conditions and prostate cancer,their diagnosis,imaging,multidisciplinary treatment,and preventive care.The meeting has been organized every 2 years in the United States,Japan,and Turkey with new colleagues joining the team.In the recent years,the IPF meetings have attracted further attention and were organized with the American Urological Association congress,the Japanese Urological Association of Urology congress,and the Turkish Association of Urology congress.Table 1 summarizes the dates of the meetings,locations,and chairmen.Mevlana Derya Balbay Abdullah Erdem Canda 2019Asian Journal of Andrology2019,21,1:0
8Comment on roles of tissue plasminogen activator and its inhibitor in proliferative diabetic retinopathy显示文摘Dear Sir,We congratulate Wu et al[1] for their study entitled'Roles of tissue plasminogen activator and its inhibitor in proliferative diabetic retinopathy'.The authors investigated the effects of tissue plasminogen activator(t-PA)and plasminogen activator inhibitor(PAI)in the pathogenesis of proliferative diabetic retinopathy(PDR).The authors reported that t-PA and PAI are involved in the pathogenesis of PDR.Abdullah Ilhan Umit Yolcu Uzeyir Erdem 2016International Journal of Ophthalmology(English edition)2016,9,7:0
9The predictors of long-COVID in the cohort of Turkish Thoracic Society-TURCOVID multicenter registry:One year follow-up results显示文摘Objective:To evaluate long-term effects of COVID-19,and to determine the risk factors in long-COVID in a cohort of the Turkish Thoracic Society(TTS)-TURCOVID multicenter registry.Methods:Thirteen centers participated with 831 patients;504 patients were enrolled after exclusions.The study was designed in three-steps:(1)Phone questionnaire;(2)retrospective evaluation of the medical records;(3)face-to-face visit.Results:In the first step,93.5%of the patients were hospitalized;61.7%had a history of pneumonia at the time of diagnosis.A total of 27.1%reported clinical symptoms at the end of the first year.Dyspnea(17.00%),fatigue(6.30%),and weakness(5.00%)were the most prevalent long-term symptoms.The incidence of long-term symptoms was increased by 2.91 fold(95%CI 1.04-8.13,P=0.041)in the presence of chronic obstructive pulmonary disease and by 1.84 fold(95%CI 1.10-3.10,P=0.021)in the presence of pneumonia at initial diagnosis,3.92 fold(95%CI 2.29-6.72,P=0.001)of dyspnea and 1.69 fold(95%CI 1.02-2.80,P=0.040)fatigue persists in the early-post-treatment period and 2.88 fold(95%CI 1.52-5.46,P=0.001)in the presence of emergency service admission in the post COVID period.In step 2,retrospective analysis of 231 patients revealed that 1.4%of the chest X-rays had not significantly improved at the end of the first year,while computed tomography(CT)scan detected fibrosis in 3.4%.In step 3,138(27.4%)patients admitted to face-to-face visit at the end of first year;at least one symptom persisted in 49.27%patients.The most common symptoms were dyspnea(27.60%),psychiatric symptoms(18.10%),and fatigue(17.40%).Thorax CT revealed fibrosis in 2.4%patients.Conclusions:COVID-19 symptoms can last for extended lengths of time,and severity of the disease as well as the presence of comorbidities might contribute to increased risk.Long-term clinical issues should be regularly evaluated after COVID-19.Serap Argun Baris Oya Baydar Toprak Pelin Duru Cetinkaya Fusun Fakili Nurdan Kokturk Seval Kul Ozgecan Kayalar Yildiz Tutuncu Emel Azak Mutlu Kuluozturk Pinar Aysert Yildiz Pelin Pinar Deniz Oguz Kilinc Ilknur Basyigit Hasim Boyaci Ismail Hanta Neslihan Kose Gulseren Sagcan Caglar Cuhadaroglu Hacer Kuzu Okur Hasan Selcuk Ozger Begum Ergan Mehtap Hafizoglu Abdullah Sayiner Esra Nurlu Temel Onder Ozturk Tansu Ulukavak Ciftci Ipek Kivilcim Oguzulgen Vildan Avkan Oguz Firat Bayraktar Ozlem Ataoglu Merve Ercelik Pinar Yildiz Gulhan Aysegul Tomruk Erdem Muge Meltem Tor Oya Itil Hasan Bayram 2022Asian Pacific Journal of Tropical Medicine2022,15,9:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费